MELINDA CAMPBELL: Open Payments
NPI 1164946612 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 63 payments from 28 companies in 2025. Trend: 2023 $534 · 2024 $1,009 · 2025 $1,440
Food & beverage: $1,302Education: $138
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| ABBVIE INC. | 4 | $122 |
| SEAGEN INC. | 1 | $95 |
| Celgene Corporation | 4 | $78 |
| PFIZER INC. | 6 | $73 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| BeOne Medicines USA, Inc. | 3 | $68 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Genentech USA, Inc. | 2 | $54 |
Products named: IMBRUVICA, Fabhalta, REBLOZYL, KEYTRUDA, ENHERTU, DATROWAY, BRUKINSA, MONJUVI.
Industry payments across OH — which companies pay providers there.
